Equillium, Inc. (EQ)
2.20
-0.11
(-4.76%)
USD |
NASDAQ |
Aug 24, 16:00
2.24
+0.04
(+1.82%)
After-Hours: 20:00
Equillium Price to Book Value : 2.490 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 2.490 |
| August 21, 2026 | 2.615 |
| August 20, 2026 | 2.570 |
| August 19, 2026 | 2.638 |
| August 18, 2026 | 2.660 |
| August 17, 2026 | 2.807 |
| August 14, 2026 | 2.671 |
| August 13, 2026 | 2.275 |
| August 12, 2026 | 2.468 |
| August 11, 2026 | 2.524 |
| August 10, 2026 | 2.479 |
| August 07, 2026 | 2.388 |
| August 06, 2026 | 2.400 |
| August 05, 2026 | 2.479 |
| August 04, 2026 | 2.558 |
| August 03, 2026 | 2.490 |
| July 31, 2026 | 2.490 |
| July 30, 2026 | 2.626 |
| July 29, 2026 | 2.581 |
| July 28, 2026 | 2.626 |
| July 27, 2026 | 2.785 |
| July 24, 2026 | 2.819 |
| July 23, 2026 | 3.045 |
| July 22, 2026 | 3.124 |
| July 21, 2026 | 2.977 |
| Date | Value |
|---|---|
| July 20, 2026 | 2.796 |
| July 17, 2026 | 2.932 |
| July 16, 2026 | 2.830 |
| July 15, 2026 | 2.966 |
| July 14, 2026 | 3.124 |
| July 13, 2026 | 3.260 |
| July 10, 2026 | 3.294 |
| July 09, 2026 | 3.351 |
| July 08, 2026 | 3.566 |
| July 07, 2026 | 3.260 |
| July 06, 2026 | 3.136 |
| July 02, 2026 | 3.294 |
| July 01, 2026 | 3.441 |
| June 30, 2026 | 3.622 |
| June 29, 2026 | 3.274 |
| June 26, 2026 | 3.242 |
| June 25, 2026 | 3.136 |
| June 24, 2026 | 3.029 |
| June 23, 2026 | 3.018 |
| June 22, 2026 | 3.040 |
| June 18, 2026 | 3.242 |
| June 17, 2026 | 3.178 |
| June 16, 2026 | 2.923 |
| June 15, 2026 | 2.976 |
| June 12, 2026 | 2.987 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ironwood Pharmaceuticals, Inc. | -- |
| Fortress Biotech, Inc. | 0.5946 |
| Cue Biopharma, Inc. | 52.48 |
| Legend Biotech Corp. | 3.300 |
| Dianthus Therapeutics, Inc. | 5.146 |
Price to Book Value Related Metrics
| Price | 2.20 |
| Earnings Yield | -9.23% |
| Market Cap | 139.50M |